Monte Rosa Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$20.70

-0.01 (-0.05%)

As of Jun 24, 1:50 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +85.7% upside

Low Target $28.40

Average Target $38.45

High Target $50.36

Current Price $20.70

Current
$20.70

Target
$38.45

$28.40 $38.45 avg $50.36

Scenario Analysis

Bear Case

$28.40

37.2%

Low target

Base Case

$38.45

+85.7%

Avg target

Bull Case

$50.36

+143.3%

High target

Risk/Reward

3.9x

Highly favorable

Price in Context

52-Week High

$25.77

-19.7% from high

52-Week Low

$4.12

+402.4% from low

Target vs 52W High

$38.45

+49.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%